Skip to main content
SpringerLink
Log in

Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus

  • Diabetes and Pregnancy (CJ Homko, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Gestational diabetes mellitus (GDM) is a common complication characterized by increased insulin resistance, and by increased risk for adverse pregnancy outcomes affecting both the mother and the fetus. International guidelines describe optimal ways to recognize it, and the recommended treatment of patients affected to reduce adverse outcomes. Improving insulin resistance could reduce incidence of GDM and its complications. Recently, a few trials have been published on the possible prevention of GDM. Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Buchannan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485–91.

    Article  Google Scholar 

  2. Corrado F, Pintaudi B, Di Vieste G, et al. Italian risk-factor based screening for gestational diabetes. J Matern Fetal Med. 2014;27:1445–8.

    Article  CAS  Google Scholar 

  3. Ten WT, Teede HJ, Paul E, et al. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aus N Z J Obstet Gynaeocol. 2011;51:26–30.

    Article  Google Scholar 

  4. Ryan EA. Diagnosis gestational diabetes. Diabetologia. 2011;54:480–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. HAPO study Cooperative research Group, Metger B, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. The present study represents the mainstay of a new era in gestational diabetes diagnosis.

    Article  Google Scholar 

  6. Geimlueck CJ, Panikoff J, Aregawi D, et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril. 2088;89:625–34.

    Article  Google Scholar 

  7. Vanky E, Stridklev S, Heimstad R, et al. Metformine versus placebo from first trimester to delivery in plycystic ovary syndrome: a randomized controlled multicenter study. J Clin Endocrinol Metab. 2010;95:E445–8.

    Article  Google Scholar 

  8. Chau JFL, Lee JWS, Law SK, et al. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J. 2005;19:1887–9.

    CAS  PubMed  Google Scholar 

  9. Dai Z, Chung D, Miao KS, Lau AWH. Sodium/myo-inositol cotransporter-1 and myo-inositol are essential for osteogenesis and bone formation. J Bone Miner Res. 2011;26:582–90.

    Article  CAS  PubMed  Google Scholar 

  10. Carlomagno G, Unfer V, Buffo S, et al. Myo-inositol in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol. 2011;26:526–30.

    Article  Google Scholar 

  11. Unfer V, Carlomagno G, Dante G, et al. Effects of myo-inositl in women with PCOs: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28:569–75.

    Article  Google Scholar 

  12. Ciotta L, Stradacquadanio M, Pagano I, et al. Effects of myo-inositol supplementation on oocyte’s quality in PCOs patients: a double blind trial. Eur Rev Med Pharmacol Sci. 2011;15:509–14.

    CAS  PubMed  Google Scholar 

  13. Unfer V, Carlomagno G, Rizzo P, et al. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011;15:452–7.

    CAS  PubMed  Google Scholar 

  14. Condorelli RA, La Vignera S, Di Bari F, et al. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011;15:129–34.

    CAS  PubMed  Google Scholar 

  15. Condorelli RA, La Vignera S, Bellanca S, et al. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79:1290–5.

    Article  PubMed  Google Scholar 

  16. Santamaria A, Giordano D, Corrado F, et al. One-year effects of myo-inositol supplementation in post-menopausal women with metabolic syndrome. Climateric. 2012;15:490–5.

    Article  CAS  Google Scholar 

  17. Croze ML, Vella RE, Pillon NJ, et al. Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice. J Nutr Biochem. 2013;24:457–66.

    Article  CAS  PubMed  Google Scholar 

  18. Maeba R, Hara H, Ishikawa H, et al. Myo-inositol treatment increases serum plasmaogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. J Nutr Sci Vitaminol. 2008;54:196–202.

    Article  CAS  PubMed  Google Scholar 

  19. Ortmeyer HK. Dietary myoinositol in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys. Obes Res. 1996;4:569–75.

    Article  CAS  PubMed  Google Scholar 

  20. Croze L, Soulage C. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95:1811–27. The present review represents a complete description of myo-inositol in medicine.

    Article  CAS  PubMed  Google Scholar 

  21. Malvasi A, Casciaro F, Minervini MM, et al. Myo-inositol, D-Chiro- inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. Eur Rev Med Pharmacol Sci. 2014;18:270–4. This is the first description of different inositol stereoisomers in pregnancy.

    CAS  PubMed  Google Scholar 

  22. Saltier AR. Second messenger of insulin action. Diabetes Care. 1990;13:244–56.

    Article  Google Scholar 

  23. Corrado F, D'Anna R, Di Vieste G. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28:972–5. The present study is a controlled trial in GDM treatment with myo-inositol.

    Article  CAS  PubMed  Google Scholar 

  24. D’Anna R, Scilipoti A, Giordano D, et al. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes. Diabetes Care. 2013;36:854–7. This study compared myo-inositol and placebo in a high-risk population.

  25. Matarrelli B, Vitacolonna E, D'Angelo, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26:967–72. This is a controlled double-blind controlled trial.

    Article  CAS  PubMed  Google Scholar 

  26. D’Anna R, Di Benedetto A, Scilipoti A. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women. Obstet Gynecol. 2015;126:310–5. The study exposed obese pregnant women to myo-inositol.

    Article  PubMed  Google Scholar 

  27. Kennington AS, Hill CR, Craig J, et al. Low urinary chiro-inositol excretion in noninsulin-dependent diabetes mellitus. N Engl J Med. 1990;323:373–8.

    Article  CAS  PubMed  Google Scholar 

  28. Ortmeyer HK, Huang LC, Zhang L, et al. Chiroinositol deficiency and insulin resistance acute effects of D-Chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistance rhesus monkeys. Endocrinology. 1993;132:646.

    CAS  PubMed  Google Scholar 

  29. Ortmeyer HK, Huang LC, Zhang L. Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. Obes Res. 1995;3 Suppl 4:605S–8.

    Article  CAS  PubMed  Google Scholar 

  30. Ortmeyer HK. DIetary myo-inositol results in lower urine glucose and in lower post-prandialplasma glucose in obese insulin resistant rhesus monkey. Obes Res. 1996;4:569–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University “G. d’Annunzio” Chieti, Chieti, Italy

    Claudio Celentano, Barbara Matarrelli, Giulia Pavone & Marco Liberati

  2. Department of Ophtalmology, University “G. d’Annunzio” Chieti, via dei Vestini, 66100, Chieti, Italy

    Peter A. Mattei

  3. Department of Internal Medicine, University “G. d’Annunzio” Chieti, Chieti, Italy

    Ester Vitacolonna

Authors
  1. Claudio Celentano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Matarrelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter A. Mattei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giulia Pavone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ester Vitacolonna
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marco Liberati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Celentano.

Ethics declarations

Conflict of Interest

Claudio Celentano, Barbara Matarrelli, Peter A. Mattei, Giulia Pavone, Ester Vitacolonna, and Marco Liberati declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article contains a study with human subjects performed by some of the authors. The paper for reference 30 received local ethical committee approval and clinical trial registration as described in the M&M section.

Additional information

This article is part of the Topical Collection on Diabetes and Pregnancy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Celentano, C., Matarrelli, B., Mattei, P.A. et al. Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus. Curr Diab Rep 16, 30 (2016). https://doi.org/10.1007/s11892-016-0726-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-016-0726-6

Keywords

Search

Navigation